data

Digital

2023 predictions and challenges in the healthcare business

With a new year comes an opportunity for professionals in the healthcare industry to evaluate goals and initiatives for 2023.

R&D

6 research and development life science predictions for 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences tea

Patients

European Health Data Space (EHDS) update: what this means fo...

The proposed EHDS Regulation1 (Proposal), introduced in May 2022 by the European Commission (EC), aims to reform the “situation of fragmentation” that depicts th

R&D

How decentralised storage networks can change the game for t...

The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about

Patients

Access solutions: the missing link that prevents biopharma i...

We live in unprecedented times, where innovation in biosciences continues to accelerate.

Oncology

Economist Impact: World Cancer Series – pharmaphorum in atte...

To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and e